BR112016018371A2 - derivado de indolona substituído com pirrol, método de preparação do mesmo, composição compreendendo o mesmo e uso do mesmo - Google Patents
derivado de indolona substituído com pirrol, método de preparação do mesmo, composição compreendendo o mesmo e uso do mesmoInfo
- Publication number
- BR112016018371A2 BR112016018371A2 BR112016018371A BR112016018371A BR112016018371A2 BR 112016018371 A2 BR112016018371 A2 BR 112016018371A2 BR 112016018371 A BR112016018371 A BR 112016018371A BR 112016018371 A BR112016018371 A BR 112016018371A BR 112016018371 A2 BR112016018371 A2 BR 112016018371A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrrol
- preparation
- composition
- same
- indolone derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410046278.2 | 2014-02-10 | ||
| CN201410046278.2A CN104829596B (zh) | 2014-02-10 | 2014-02-10 | 吡咯取代吲哚酮类衍生物、其制备方法、包含该衍生物的组合物、及其用途 |
| PCT/CN2015/072230 WO2015117551A1 (zh) | 2014-02-10 | 2015-02-04 | 吡咯取代吲哚酮类衍生物、其制备方法、包含该衍生物的组合物、及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112016018371A2 true BR112016018371A2 (pt) | 2017-10-17 |
| BR112016018371B1 BR112016018371B1 (pt) | 2022-06-14 |
Family
ID=53777341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016018371-1A BR112016018371B1 (pt) | 2014-02-10 | 2015-02-04 | Derivados de indolona substituídos com pirrol, composição os compreendendo e uso dos mesmos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9556154B2 (pt) |
| EP (1) | EP3106459B1 (pt) |
| JP (1) | JP6211205B2 (pt) |
| KR (1) | KR101805693B1 (pt) |
| CN (1) | CN104829596B (pt) |
| AU (1) | AU2015215335B2 (pt) |
| BR (1) | BR112016018371B1 (pt) |
| CA (1) | CA2939012C (pt) |
| ES (1) | ES2687418T3 (pt) |
| MX (1) | MX369473B (pt) |
| MY (1) | MY176521A (pt) |
| PL (1) | PL3106459T3 (pt) |
| PT (1) | PT3106459T (pt) |
| RU (1) | RU2650682C2 (pt) |
| SA (1) | SA516371644B1 (pt) |
| SG (1) | SG11201606545SA (pt) |
| WO (1) | WO2015117551A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017079132A1 (en) | 2015-11-02 | 2017-05-11 | Dolby Laboratories Licensing Corporation | Layered representation containing crc codes and delivery of high dynamic range video |
| CN108727341B (zh) * | 2017-04-13 | 2021-02-19 | 勤浩医药（苏州）有限公司 | 一种吡咯取代吲哚酮类衍生物或其药学上可接受的盐、及它们的制备方法和用途 |
| CN108191835A (zh) * | 2018-01-09 | 2018-06-22 | 中国药科大学 | 一类新型的含吡咯环和吲哚啉结构rip1激酶抑制剂及其用途 |
| JP7154656B2 (ja) * | 2018-09-19 | 2022-10-18 | 勤浩医▲葯▼（▲蘇▼州）有限公司 | ピロール置換インドロン誘導体又はその薬学的に許容される塩、及びそれらの調製方法並びに使用 |
| CN109232580A (zh) * | 2018-11-14 | 2019-01-18 | 南阳师范学院 | 一种1H-吡咯并[1,2-a]吲哚-2(3-H)-酮的合成方法 |
| CN112321568B (zh) * | 2020-09-22 | 2023-02-17 | 南京中医药大学 | 4-甲基吡咯取代的吲哚酮衍生物、其制备方法及其医药用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2399358C (en) | 2000-02-15 | 2006-03-21 | Sugen, Inc. | Pyrrole substituted 2-indolinone protein kinase inhibitors |
| JP2004518669A (ja) * | 2000-12-20 | 2004-06-24 | スージェン・インコーポレーテッド | ４−アリール置換インドリノン |
| WO2002081466A1 (en) * | 2001-04-09 | 2002-10-17 | Sugen, Inc. | Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| JP2005508953A (ja) * | 2001-10-10 | 2005-04-07 | スージェン・インコーポレーテッド | キナーゼ阻害剤としての３−［４−（置換ヘテロサイクリル）−ピロール−２−イルメチリデン］−２−インドリノン誘導体 |
| BR0214357A (pt) * | 2001-11-21 | 2004-09-14 | Sugen Inc | Formulações farmacêuticas compreendendo derivados de indolinona |
| HN2003000272A (es) * | 2002-09-10 | 2008-07-29 | Pharmacia Italia Spa | Formulaciones que comprenden un compuesto de indolinona |
| CN101007801A (zh) * | 2006-01-27 | 2007-08-01 | 上海恒瑞医药有限公司 | 吡咯取代的2－二氢吲哚酮衍生物、其制法与医药上的用途 |
| AU2007294686B2 (en) * | 2006-09-15 | 2013-10-31 | Equinox Sciences, Llc | Kinase inhibitor compounds |
| WO2009071523A1 (en) * | 2007-12-03 | 2009-06-11 | Boehringer Ingelheim International Gmbh | Process for the manufacture of an indolinone derivative |
| EP2292613B1 (en) * | 2008-05-23 | 2015-09-30 | Shanghai Institute of Pharmaceutical Industry | Dihydroindolinone derivatives |
| CN102276584A (zh) * | 2010-06-08 | 2011-12-14 | 齐鲁制药有限公司 | 吡咯取代的2-二氢吲哚酮衍生物、其制备方法及用途 |
| CN103130744B (zh) | 2012-08-28 | 2014-10-15 | 沈阳药科大学 | 一种硒唑甲酸类化合物及其制备方法和用途 |
-
2014
- 2014-02-10 CN CN201410046278.2A patent/CN104829596B/zh active Active
-
2015
- 2015-02-04 US US15/117,400 patent/US9556154B2/en active Active
- 2015-02-04 BR BR112016018371-1A patent/BR112016018371B1/pt active IP Right Grant
- 2015-02-04 JP JP2016552314A patent/JP6211205B2/ja active Active
- 2015-02-04 ES ES15746066.8T patent/ES2687418T3/es active Active
- 2015-02-04 PL PL15746066T patent/PL3106459T3/pl unknown
- 2015-02-04 MY MYPI2016702887A patent/MY176521A/en unknown
- 2015-02-04 EP EP15746066.8A patent/EP3106459B1/en active Active
- 2015-02-04 WO PCT/CN2015/072230 patent/WO2015117551A1/zh active Application Filing
- 2015-02-04 AU AU2015215335A patent/AU2015215335B2/en active Active
- 2015-02-04 RU RU2016136351A patent/RU2650682C2/ru active
- 2015-02-04 CA CA2939012A patent/CA2939012C/en active Active
- 2015-02-04 SG SG11201606545SA patent/SG11201606545SA/en unknown
- 2015-02-04 PT PT15746066T patent/PT3106459T/pt unknown
- 2015-02-04 MX MX2016010272A patent/MX369473B/es active IP Right Grant
- 2015-02-04 KR KR1020167024807A patent/KR101805693B1/ko active IP Right Grant
-
2016
- 2016-08-09 SA SA516371644A patent/SA516371644B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201606545SA (en) | 2016-09-29 |
| SA516371644B1 (ar) | 2019-08-29 |
| RU2016136351A3 (pt) | 2018-03-15 |
| JP2017505803A (ja) | 2017-02-23 |
| WO2015117551A1 (zh) | 2015-08-13 |
| KR101805693B1 (ko) | 2017-12-06 |
| MX369473B (es) | 2019-11-08 |
| MY176521A (en) | 2020-08-13 |
| EP3106459A1 (en) | 2016-12-21 |
| PL3106459T3 (pl) | 2018-11-30 |
| CN104829596A (zh) | 2015-08-12 |
| KR20160117605A (ko) | 2016-10-10 |
| CA2939012C (en) | 2018-11-06 |
| AU2015215335B2 (en) | 2017-07-27 |
| US9556154B2 (en) | 2017-01-31 |
| CA2939012A1 (en) | 2015-08-13 |
| AU2015215335A1 (en) | 2016-09-01 |
| JP6211205B2 (ja) | 2017-10-11 |
| RU2650682C2 (ru) | 2018-04-17 |
| CN104829596B (zh) | 2017-02-01 |
| EP3106459A4 (en) | 2017-07-12 |
| MX2016010272A (es) | 2017-02-06 |
| PT3106459T (pt) | 2018-10-18 |
| US20160347740A1 (en) | 2016-12-01 |
| BR112016018371B1 (pt) | 2022-06-14 |
| EP3106459B1 (en) | 2018-07-04 |
| RU2016136351A (ru) | 2018-03-15 |
| ES2687418T3 (es) | 2018-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016002364A1 (es) | Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas | |
| CL2018000813A1 (es) | Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso. | |
| BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
| HK1243999A1 (zh) | 新型3-吲哚取代的衍生物、藥物組合物及使用方法 | |
| ES2796903T8 (es) | Procedimiento de uso de inmunoconjugados anti-CD79b | |
| DK3697376T3 (da) | Sammensætning | |
| DK3104718T3 (da) | Tobaksholdig gelsammensætning | |
| BR112016025246A2 (pt) | composição de preservativo de madeira | |
| BR112016030968A2 (pt) | análogos de pridopidina, preparação e uso destes | |
| ES2965669T3 (es) | Composición | |
| CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
| EP3115361A4 (en) | Heterocyclic compounds, and preparation method and use thereof | |
| EP3157515A4 (en) | Platinum compounds, compositions, and uses thereof | |
| BR112016006614A2 (pt) | composições de trichoderma e métodos de uso | |
| EP3159344A4 (en) | Amino pyranoid ring derivative and composition and use thereof | |
| BR112016018371A2 (pt) | derivado de indolona substituído com pirrol, método de preparação do mesmo, composição compreendendo o mesmo e uso do mesmo | |
| BR112017005126A2 (pt) | compostos citotóxicos e antimitóticos e métodos de uso dos mesmos. | |
| BR112016019868A2 (pt) | proteínas de fusão tatk-cdkl5, composições, formulações, e seu uso | |
| BR112017012240A2 (pt) | métodos de preparação de composições contendo alcaloides e suas utilizações | |
| BR112016021231A2 (pt) | derivados de hexose, preparação e uso destes. | |
| ES1209313Y (es) | Composicion liofilizada | |
| FI20155976A (fi) | Menetelmä liima-ainekoostumuksen valmistamiseksi, liima-ainekoostumus ja sen käyttö | |
| BR112017013928A2 (pt) | composição alimentar e método de uso. | |
| EP3199639A4 (en) | Novel measurement method using kinase, and composition | |
| FR3019000B1 (fr) | Composition de clomazone, sa preparation et son utilisation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/02/2015, OBSERVADAS AS CONDICOES LEGAIS |